-+ 0.00%
-+ 0.00%
-+ 0.00%

HUMACYTE ANNOUNCES FDA ACCEPTANCE OF IND FOR FIRST-IN-HUMAN CLINICAL STUDY OF CTEV FOR CORONARY ARTERY BYPASS GRAFTING

Reuters·07/27/2026 12:00:05

Please log in to view news